
Found 7 results
Filters: Author is Kutok, JL [Clear All Filters]
Search Results
- Showing 1-7 of 7 Results
Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma. Cancer cell, 2012/09/11, Volume 22, Issue 3, p.359-72, (2012)
Read More / View Supplemental Materials
Abstract
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program. Proceedings of the National Academy of Sciences of the United States of America, 2011/02/15, Volume 108, Issue 7, p.2873-8, (2011)
Read More / View Supplemental Materials
Abstract
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma. Blood, 2010/10/28, Volume 116, Issue 17, p.3268-77, (2010)
Read More / View Supplemental Materials
Abstract
A zebrafish bmyb mutation causes genome instability and increased cancer susceptibility. Proceedings of the National Academy of Sciences of the United States of America, 2005/09/13, Volume 102, Issue 37, p.13194-9, (2005)
Read More / View Supplemental Materials
Abstract
NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes. Blood, 2005/08/15, Volume 106, Issue 4, p.1392-9, (2005)
Read More / View Supplemental Materials
Abstract
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood, 2005/03/01, Volume 105, Issue 5, p.1851-61, (2005)
Read More / View Supplemental Materials
Abstract
Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease. The EMBO journal, 2005/01/26, Volume 24, Issue 2, p.368-81, (2005)
Read More / View Supplemental Materials
Abstract
- Showing 1-7 of 7 Results




